Europe — EMA
Convyval (Sodium Valproate)
Convyval is a medication containing Sodium Valproate, used for various therapeutic purposes. It is an oral medication manufactured by Makpharm D.O.O. in the EU.
Request sourcing
What is Sodium Valproate?
Convyval is a medication containing Sodium Valproate, used for various therapeutic purposes. It is an oral medication manufactured by Makpharm D.O.O. in the EU.
What is Sodium Valproate used for?
Convyval, containing Sodium Valproate, is commonly used for managing certain types of seizures and as a mood stabilizer. It may also be prescribed for conditions like migraines or bipolar disorder. The primary use of Sodium Valproate is to help control abnormal brain activity, which can be beneficial for those experiencing seizures or mood disorders.
What are the side effects of Sodium Valproate?
Common effects of Convyval may include drowsiness, dizziness, and nausea. Some users might experience weight changes or tremors. These effects can vary from person to person and may subside as the body adjusts to the medication.
What precautions apply to Sodium Valproate?
Convyval should be handled with care, especially by individuals with liver or pancreatic conditions. It is important to follow the advice of a healthcare professional regarding its use. Pregnant women should consult their doctor before taking this medication.
What does Sodium Valproate interact with?
Convyval may interact with other medications, including those that affect the central nervous system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using Convyval.



